Istodax (Romidepsin Vials) 10mg

Romidepsin is an antineoplastic agent available as 10mg vials for injection. This chemotherapy medication is used to treat certain types of lymphoma. It works by slowing or stopping the growth of cancer cells.

Strength

10mg

Manufacturer / TM Owner

Baxter Oncology Gmbh

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Romidepsin is primarily used to treat cutaneous T-cell lymphoma and peripheral T-cell lymphoma in adults whose cancer has returned after treatment or has not improved with other therapies. It belongs to a class of drugs known as histone deacetylase inhibitors, which help control the growth of cancer cells. Patients often ask, 'what is romidepsin used for' when prescribed this treatment.

Side Effects

Romidepsin may help reduce symptoms related to lymphoma by slowing disease progression. Common effects include fatigue, nausea, and changes in blood cell counts. Some patients experience gastrointestinal discomfort or skin reactions during treatment.

Precautions & Warnings

Romidepsin should be administered under medical supervision by healthcare professionals. Patients should report any signs of infection, bleeding, or unusual symptoms immediately. Regular blood tests are typically required to monitor treatment progress and manage potential side effects.

Avoid Interactions

Romidepsin may interact with other medications, including CYP3A4 inhibitors or inducers, which can affect its effectiveness. Patients should inform their doctor about all prescription, over-the-counter, and herbal products they are using. Alcohol and certain supplements may also interact with romidepsin.

References

Frequently Asked Questions

Romidepsin is used to treat certain types of lymphoma, including cutaneous T-cell lymphoma and peripheral T-cell lymphoma.

Romidepsin is given as an intravenous injection by a healthcare professional in a clinical setting.

Common side effects may include fatigue, nausea, and changes in blood cell counts.

Patients should consult their doctor before taking any other medications, including over-the-counter drugs and supplements.

Yes, romidepsin is a chemotherapy medication used to treat certain types of cancer.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.